Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,129 | 4,082 | -47,671 | -30,993 | -18,689 |
| Depreciation Amortization | 416 | 160 | 575 | 414 | 282 |
| Accounts payable and accrued liabilities | 46 | -1,065 | -1,763 | -1,409 | -1,214 |
| Other Working Capital | -31,759 | -30,748 | -42,690 | -32,677 | -23,826 |
| Other Operating Activity | 5,998 | 3,550 | 8,293 | 6,142 | 3,955 |
| Operating Cash Flow | $-49,428 | $-24,021 | $-83,256 | $-58,523 | $-39,492 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -268 | -151 | -344 | -208 | -57 |
| Net Acquisitions | N/A | N/A | 1 | N/A | N/A |
| Investing Cash Flow | $-268 | $-151 | $-343 | $-208 | $-57 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,000 | N/A | 20,000 | 20,000 | 20,000 |
| Debt Repayment | N/A | N/A | N/A | -45 | N/A |
| Common Stock Issued | 832 | 332 | 109,570 | 109,281 | 244 |
| Other Financing Activity | -2,240 | -3 | -923 | -637 | -251 |
| Financing Cash Flow | $58,592 | $329 | $128,647 | $128,599 | $19,993 |
| Beginning Cash Position | 129,780 | 129,780 | 84,732 | 84,732 | 84,732 |
| End Cash Position | 138,676 | 105,937 | 129,780 | 154,600 | 65,176 |
| Net Cash Flow | $8,896 | $-23,843 | $45,048 | $69,868 | $-19,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,428 | -24,021 | -83,256 | -58,523 | -39,492 |
| Capital Expenditure | -268 | -151 | -344 | -208 | -57 |
| Free Cash Flow | -49,696 | -24,172 | -83,600 | -58,731 | -39,549 |